Ying Jian

Precision medicine for resistant hypertension: integrating molecular phenotyping, gut microbiome, device therapy and digital care

Abstract Resistant hypertension confers substantial cardiovascular and renal risk. However, apparent treatment resistance often arises from reversible problems rather than a discrete biological disease. Precision management starts with confirming true resistant hypertension through standardized office measurement, out-...